Literature DB >> 15955282

Immunomodulatory effect of plasmids co-expressing cytokines in classical swine fever virus subunit gp55/E2-DNA vaccination.

Daniel Wienhold1, Elisenda Armengol, Annette Marquardt, Christian Marquardt, Heiner Voigt, Mathias Büttner, Armin Saalmüller, Eberhard Pfaff.   

Abstract

The aim of this study was to determine the immunomodulatory effects of IL-12, IL-18 and CD154 (CD40 ligand, CD40L) in DNA-vaccination against the classical swine fever virus. Four recombinant plasmids were constructed including the CSFV coding region for the glycoprotein gp55/E2 alone or together with porcine IL-12, IL-18 or CD154 genes. Five groups of four pigs each were immunized intramuscularly (i.m.) three times with the respective constructs. The control group was inoculated with empty plasmid DNA. Eighteen days after the final immunization, the pigs were challenged with a lethal dose of CSFV strain Eystrup and monitored for a further 16 days. This study showed that co-delivery of IL-18 and CD154 induced an earlier appearance of serum antibodies, reduced B-cell deficiency after infection and protected pigs against a lethal CSFV infection. In contrast, co-delivery of IL-12 led to a reduced titer of neutralizing antibodies and protection against a lethal CSFV challenge in comparison to the other pigs and to pigs that were immunized with a gp55/E2 plasmid alone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955282     DOI: 10.1051/vetres:2005019

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  8 in total

1.  Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.

Authors:  Geoffrey W Stone; Suzanne Barzee; Victoria Snarsky; Kristin Kee; Celsa A Spina; Xiao-Fang Yu; Richard S Kornbluth
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.

Authors:  Suefen Kwa; Lilin Lai; Sailaja Gangadhara; Mariam Siddiqui; Vinod B Pillai; Celia Labranche; Tianwei Yu; Bernard Moss; David C Montefiori; Harriet L Robinson; Pamela A Kozlowski; Rama Rao Amara
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.

Authors:  Ileanet Ávalos; Thailin Lao; Elsa María Rodríguez; Yasser Zamora; Alianet Rodríguez; Ailyn Ramón; Gilda Lemos; Ania Cabrales; Monica Bequet-Romero; Dionne Casillas; Ivan Andújar; Luis Ariel Espinosa; Luis Javier González; Yanitza Alvarez; Yamila Carpio; Mario Pablo Estrada
Journal:  Vaccines (Basel)       Date:  2022-06-03

4.  A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.

Authors:  Mark Melchers; Katie Matthews; Robert P de Vries; Dirk Eggink; Thijs van Montfort; Ilja Bontjer; Carolien van de Sandt; Kathryn David; Ben Berkhout; John P Moore; Rogier W Sanders
Journal:  Retrovirology       Date:  2011-06-20       Impact factor: 4.602

Review 5.  DNA vaccines and their applications in veterinary practice: current perspectives.

Authors:  K Dhama; Mahesh Mahendran; P K Gupta; A Rai
Journal:  Vet Res Commun       Date:  2008-04-19       Impact factor: 2.459

Review 6.  The Key Role of Nucleic Acid Vaccines for One Health.

Authors:  Anders Fomsgaard; Margaret A Liu
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

7.  CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.

Authors:  Patricia Renson; Mireille Le Dimna; André Keranflech; Roland Cariolet; Frank Koenen; Marie-Frédérique Le Potier
Journal:  Vet Res       Date:  2013-02-11       Impact factor: 3.683

8.  Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine.

Authors:  Pinghua Li; Zengjun Lu; Xingwen Bai; Dong Li; Pu Sun; Huifang Bao; Yuanfang Fu; Yimei Cao; Yingli Chen; Baoxia Xie; Hong Yin; Zaixin Liu
Journal:  Vet Res       Date:  2014-05-01       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.